SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways.
| Autor: | Li Ma, Rongjun Zou, Wanting Shi, Na Zhou, Shaoxian Chen, Hao Zhou, Xinxin Chen, Yueheng Wu |
|---|---|
| Zdroj: | Theranostics; 2022, Vol. 12 Issue 11, p5034-5050, 17p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|